Nicasia Beebe-Wang

Nicasia Beebe-Wang

Auto-generated profile, based on publicly available information

Nicasia Beebe-Wang

Paul G. Allen School of Computer Science and Engineering, University of Washington , Seattle , WA 98103 , USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
SCSafiye Celik
Safiye Celik
EWEthan Weinberger
Ethan Weinberger
PSPascal Sturmfels
Pascal Sturmfels
PJPhilip L. De Jager
Philip L. De Jager
SLSu-In Lee
Su-In Lee
Deep neural networks (DNNs) capture complex relationships among variables, however, because they require copious samples, their potential has yet to be fully tapped for understanding relationships between gene expression and human phenotypes. Here we introduce an analysis framework, namely MD-AD (Multi-task Deep learning for Alzheimer’s Disease neuropathology), which leverages an unexpected synergy between DNNs and multi-cohort settings. In these settings, true joint analysis can be stymied using conventional statistical methods, which require “harmonized” phenotypes and tend to capture cohort-level variations, obscuring subtler true disease signals. Instead, MD-AD incorporates related phenotypes sparsely measured across cohorts, and learns interactions between genes and phenotypes not discovered using linear models, identifying subtler signals than cohort-level variations which can be uniquely recapitulated in animal models and across tissues. We show that MD-AD exploits sex-specific relationships between microglial immune response and neuropathology, providing a nuanced context for the association between inflammatory genes and Alzheimer’s Disease.

17 February 2021 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
AOAlex Okeson
Alex Okeson
TATim Althoff
Tim Althoff
SLSu-In Lee
Su-In Lee
As the aging US population grows, scalable approaches are needed to identify individuals at risk for dementia. Common prediction tools have limited predictive value, involve expensive neuroimaging, or require extensive and repeated cognitive testing. None of these approaches scale to the sizable aging population who do not receive routine clinical assessments. Our study seeks a tractable and widely administrable set of metrics that can accurately predict imminent (i.e., within three years) dementia onset. To this end, we develop and apply a machine learning (ML) model to an aging cohort study with an extensive set of longitudinal clinical variables to highlight at-risk individuals with better accuracy than standard rudimentary approaches. Next, we reduce the burden needed to achieve accurate risk assessments for those deemed at risk by (1) predicting when consecutive clinical visits may be unnecessary, and (2) selecting a subset of highly predictive cognitive tests. Finally, we demonstrate that our method successfully provides individualized prediction explanations that retain non-linear feature effects present in the data. Our final model, which uses only four cognitive tests (less than 20 minutes to administer) collected in a single visit, affords predictive performance comparable to a standard 100-minute neuropsychological battery and personalized risk explanations. Our approach shows the potential for an efficient tool for screening and explaining dementia risk in the general aging population.

24 June 2022 in NAR Genomics and Bioinformatics
Verified
Journal Article
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
ADAyse B Dincer
Ayse B Dincer
SLSu-In Lee
Su-In Lee
Although knowledge of biological pathways is essential for interpreting results from computational biology studies, the growing number of pathway databases complicates efforts to efficiently perform pathway analysis due to high redundancies among pathways from different databases, and inconsistencies in how pathways are created and named. We introduce the PAthway Communities (PAC) framework, which reconciles pathways from different databases and reduces pathway redundancy by revealing informative groups with distinct biological functions. Uniquely applying the Louvain community detection algorithm to a network of 4847 pathways from KEGG, REACTOME and Gene Ontology databases, we identify 35 distinct and automatically annotated communities of pathways and show that they are consistent with expert-curated pathway categories. Further, we demonstrate that our pathway community network can be queried with new gene sets to provide biological context in terms of related pathways and communities. Our approach, combined with an interpretable web tool we provide, will help computational biologists more efficiently contextualize and interpret their biological findings.

27 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
SCSafiye Celik
Safiye Celik
SLSu-In Lee
Su-In Lee
Systematic modeling of Alzheimer’s Disease (AD) neuropathology based on brain gene expression would provide valuable insights into the disease. However, relative scarcity and regional heterogeneity of brain gene expression and neuropathology datasets obscure the ability to robustly identify expression markers. We propose MD-AD (Multi-task Deep learning for AD) to effectively combine heterogeneous AD datasets by simultaneously modeling multiple phenotypes with shared layers. MD-AD leads to an 8% and 5% reduction in mean squared error over MLP for predicting counts of two AD hallmarks: plaques and tangles. It also leads to a 40% and 30% reduction in classification error over MLP for two common staging systems for AD: CERAD score and Braak stage. Additionally, MD-AD’s network representation tends to better capture known metabolic pathways, including some AD-related pathways. Together, these results indicate that MD-AD is particularly useful for learning expressive network representations from heterogeneous and sparsely labeled AD data.

1 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
SCSafiye Celik
Safiye Celik
EWEthan Weinberger
Ethan Weinberger
PSPascal Sturmfels
Pascal Sturmfels
PJPhilip L. De Jager
Philip L. De Jager
SLSu-In Lee
Su-In Lee
Deep neural networks offer a promising approach for capturing complex, non-linear relationships among variables. Because they require immense sample sizes, their potential has yet to be fully tapped for understanding complex relationships between gene expression and human phenotypes. Encouragingly, a growing number of diseases are being studied through consortium efforts. Here we introduce a new analysis framework, namely MD-AD ( M ulti-task D eep learning for A lzheimer’s D isease neuropathology), which leverages an unexpected synergy between deep neural networks and multi-cohort settings. In these settings, true joint analysis can be stymied using conventional statistical methods, which (1) require “harmonized” phenotypes (i.e., measured in a highly consistent manner) and (2) tend to capture cohort-level variations, obscuring the subtler true disease signals. Instead, MD-AD incorporates multiple related phenotypes sparsely measured across cohorts, and learns complex, non-linear interactions between genes and phenotypes not discovered using conventional expression data analysis methods (e.g., component analysis and module detection), enabling the model to capture subtler signals than cohort-level variations. Applied to the largest available collection of brain samples (N=1,758), we demonstrate that MD-AD learns a truly generalizable relationship between gene expression program and AD-related neuropathology. The learned program generalizes in several important ways, including recapitulation of the disease progress in animal models and across tissue types, and we show that such generalizability is not achieved by previous statistical paradigms. Its ability to identify genes with high non-linear relevance to neuropathology enabled us to identify a sex-specific relationship between neuropathology and immune response across microglia, providing a nuanced context for association between inflammatory genes and AD.